🇺🇸 Carvedilol CR in United States

13 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Bradycardia — 2 reports (15.38%)
  2. Drug Ineffective — 2 reports (15.38%)
  3. Hypersensitivity — 2 reports (15.38%)
  4. Aggression — 1 report (7.69%)
  5. Back Pain — 1 report (7.69%)
  6. Blood Glucose Increased — 1 report (7.69%)
  7. Bronchospasm — 1 report (7.69%)
  8. Cardiac Failure Congestive — 1 report (7.69%)
  9. Cerebrovascular Accident — 1 report (7.69%)
  10. Confusional State — 1 report (7.69%)

Source database →

Other Cardiovascular approved in United States

Frequently asked questions

Is Carvedilol CR approved in United States?

Carvedilol CR does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Carvedilol CR in United States?

University of Florida is the originator. The local marketing authorisation holder may differ — check the official source linked above.